新入荷 再入荷

Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget

flash sale icon タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料(
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
新品 7497円 (税込)
数量

商品詳細情報

管理番号 新品 :9264125587
中古 :9264125587-1
メーカー a8fd8c1053ee 発売日 2025-02-21 03:41 定価 8820円
カテゴリ

Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget

Overcoming imatinib resistance conferred by the BIM deletion polymorphism  in chronic myeloid leukemia with splice-switching antisense  oligonucleotides | OncotargetOvercoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides | Oncotarget,The Cancer Antioxidant Regulation System in Therapeutic ResistanceThe Cancer Antioxidant Regulation System in Therapeutic Resistance,Review of Nanoscale Approaches for Tailoring Electrode Materials for  Advanced Energy Storage Systems | ACS Applied Nano MaterialsReview of Nanoscale Approaches for Tailoring Electrode Materials for Advanced Energy Storage Systems | ACS Applied Nano Materials,A fixed phase tunable directional coupler based on coupling tuning |  Scientific ReportsA fixed phase tunable directional coupler based on coupling tuning | Scientific Reports,Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer:  Molecular Insights and Therapeutic OpportunitiesRedox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities

 

商品情報の訂正

このページに記載された商品情報に記載漏れや誤りなどお気づきの点がある場合は、下記訂正依頼フォームよりお願い致します。

訂正依頼フォーム

商品レビュー

レビューの投稿にはサインインが必要です